XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Voting
Additional Paid In Capital
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Retained Earnings
Beginning balance (in shares) at Mar. 31, 2019   119,760,132     42,149,771  
Beginning balance at Mar. 31, 2019 $ 2,065,433 $ 120 $ 2,828,922 $ (2,639) $ (1,119,063) $ 358,093
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (46,815)         (46,815)
Unrealized net investment gains (losses) 37     37    
Unrealized net gain (losses) on derivative financial instruments (11)     (11)    
Cumulative translation adjustments (1,086)     (1,086)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,590,980        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 27,488   27,488      
Issuance of common stock under employee stock purchase plan (in shares)   297,635        
Issuance of common stock under employee stock purchase plan 6,593   6,593      
Repurchase of treasury stock (in shares)         4,660,929  
Repurchase of treasury stock (111,377)       $ (111,377)  
Ending balance (in shares) at Sep. 30, 2019   121,648,747     46,810,700  
Ending balance at Sep. 30, 2019 1,940,264 $ 122 2,863,003 (3,699) $ (1,230,440) 311,278
Beginning balance (in shares) at Jun. 30, 2019   120,123,018     43,568,720  
Beginning balance at Jun. 30, 2019 2,011,435 $ 120 2,841,001 (3,184) $ (1,155,252) 328,750
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (17,472)         (17,472)
Unrealized net investment gains (losses) 2     2    
Unrealized net gain (losses) on derivative financial instruments 8     8    
Cumulative translation adjustments (525)     (525)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,228,094        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 15,409   15,409      
Issuance of common stock under employee stock purchase plan (in shares)   297,635        
Issuance of common stock under employee stock purchase plan 6,593   6,593      
Repurchase of treasury stock (in shares)         3,241,980  
Repurchase of treasury stock (75,188)       $ (75,188)  
Ending balance (in shares) at Sep. 30, 2019   121,648,747     46,810,700  
Ending balance at Sep. 30, 2019 1,940,264 $ 122 2,863,003 (3,699) $ (1,230,440) 311,278
Beginning balance (in shares) at Mar. 31, 2020   122,006,077     49,785,171  
Beginning balance at Mar. 31, 2020 1,937,919 $ 122 2,891,553 (3,160) $ (1,305,935) 355,339
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (21,106)         (21,106)
Unrealized net investment gains (losses) (107)     (107)    
Unrealized net gain (losses) on derivative financial instruments 116     116    
Cumulative translation adjustments 1,893     1,893    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,555,056        
Issuance of common stock pursuant to vesting of restricted stock units 1 $ 1        
Stock-based compensation expense for restricted stock units granted to employees 26,729   26,729      
Issuance of common stock under employee stock purchase plan (in shares)   279,812        
Issuance of common stock under employee stock purchase plan 6,475   6,475      
Repurchase of treasury stock (in shares)         481,739  
Repurchase of treasury stock (12,600)       $ (12,600)  
Ending balance (in shares) at Sep. 30, 2020   123,840,945     50,266,910  
Ending balance at Sep. 30, 2020 1,939,320 $ 123 2,924,757 (1,258) $ (1,318,535) 334,233
Beginning balance (in shares) at Jun. 30, 2020   122,353,504     49,898,334  
Beginning balance at Jun. 30, 2020 1,929,817 $ 122 2,903,055 (2,241) $ (1,309,038) 337,919
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (3,686)         (3,686)
Unrealized net investment gains (losses) (33)     (33)    
Unrealized net gain (losses) on derivative financial instruments 76     76    
Cumulative translation adjustments 940     940    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,207,629        
Issuance of common stock pursuant to vesting of restricted stock units 1 $ 1        
Stock-based compensation expense for restricted stock units granted to employees 15,227   15,227      
Issuance of common stock under employee stock purchase plan (in shares)   279,812        
Issuance of common stock under employee stock purchase plan 6,475   6,475      
Repurchase of treasury stock (in shares)         368,576  
Repurchase of treasury stock (9,497)       $ (9,497)  
Ending balance (in shares) at Sep. 30, 2020   123,840,945     50,266,910  
Ending balance at Sep. 30, 2020 $ 1,939,320 $ 123 $ 2,924,757 $ (1,258) $ (1,318,535) $ 334,233